Abstract
The contents of thymic hormones and endogenous substances with thymosin-like activity (TLA) was studied under conditions of administering thymostimulin and splenin during DMBA-induced carcinogenesis in rat mammary glands. It has been established that during latent carcinogenesis there is an inhibition of thymic endocrine function which persists in tumour-bearing animals. Injections of thymostimulin and splenin induce synthesis of substances with TLA, accompanied by an inhibition of blastoma development.
MeSH terms
-
9,10-Dimethyl-1,2-benzanthracene
-
Animals
-
Female
-
Mammary Neoplasms, Experimental / chemically induced
-
Mammary Neoplasms, Experimental / metabolism
-
Mammary Neoplasms, Experimental / physiopathology*
-
Rats
-
Thymopoietins / pharmacology*
-
Thymosin / biosynthesis*
-
Thymus Extracts / pharmacology*
-
Thymus Gland / metabolism
-
Thymus Gland / physiopathology*
-
Thymus Hormones / blood
-
Thymus Hormones / pharmacology*
Substances
-
Thymopoietins
-
Thymus Extracts
-
Thymus Hormones
-
thymostimulin
-
9,10-Dimethyl-1,2-benzanthracene
-
Thymosin
-
thymopoietin III